McKhann Chas bought XGN
June 9, 2026 · Form 4 insider transaction
McKhann Chas bought 37,500 shares of Exagen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 13 days after the transaction.
Direction
Acquired (buy-side)
Shares
37,500
Price
$0.00
Total value
N/A
InsiderMcKhann Chas
Role—
CompanyExagen Inc. (XGN)
SecurityStock Option(right to buy)
Transaction codeA: Grant or award
Transaction dateJune 9, 2026
Filing dateJune 22, 2026
Shares owned after45,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.